Reported 0 shares, down 15,000 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
|
This position's reported history falls outside the five-year preview window. A free account unlocks it.
Unlock full history
|
|||||||
Who else reported the position
17 managers reported ACORDA THERAPEUTICS INC for Q2 2020.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| WELLS FARGO & COMPANY MN | Unchanged | 20,990,000 | 0 | < 0.01% | $17,946,000 | 24 qtrs |
| Bruce & Co Inc | Unchanged | 11,500,000 | 0 | 1.62% | $7,475,000 | 4 qtrs |
| Davidson Kempner Capital Management LP | Unchanged | 0 | 0 | 0.14% | $5,823,000 | 24 qtrs |
| The Goldman Sachs Group Inc | Unchanged | 6,080,000 | 0 | < 0.01% | $5,261,000 | 5 qtrs |
| UBS OCONNOR LLC | Added | 5,310,000 | +1,310,000 | 0.1% | $4,567,000 | 7 qtrs |
| CREDIT SUISSE AG | Unchanged | 4,205,000 | 0 | < 0.01% | $3,638,000 | 14 qtrs |
| AMERIPRISE FINANCIAL INC | Unchanged | 3,500,000 | 0 | < 0.01% | $3,028,000 | 15 qtrs |
| FMR LLC | Unchanged | 0 | 0 | < 0.01% | $2,033,000 | 10 qtrs |
| PFM Health Sciences LP | Unchanged | 2,000,000 | 0 | 0.09% | $1,713,000 | 13 qtrs |
| PenderFund Capital Management Ltd | Unchanged | 1,000,000 | 0 | 0.32% | $1,183,000 | 6 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2020
- Filed
- August 13, 2020
- Filing type
- 13F-HR
- Position type
- Equity
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.